Sionna Therapeutics, Inc.
SION
$6.46
-$0.08-1.22%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -28.41% | -29.01% | -22.01% | -22.45% | -- |
| Total Depreciation and Amortization | 1.25% | -2.87% | -3.14% | 0.00% | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 49.87% | 30.92% | -2.94% | -33.47% | -- |
| Change in Net Operating Assets | 95.31% | -18.70% | 13.76% | 125.42% | -- |
| Cash from Operations | -18.79% | -28.53% | -25.59% | -26.81% | -- |
| Capital Expenditure | -157.52% | -157.52% | -1,296.30% | -63.93% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 166.53% | 133.01% | 6.71% | 6.66% | -- |
| Cash from Investing | 166.27% | 132.78% | 6.43% | 6.59% | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -96.63% | -97.11% | 146,014.89% | 176,096.55% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -100.00% | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 78.02% | 87.21% | -- | -34.05% | -- |
| Cash from Financing | -96.86% | -97.39% | 14.94% | 12.35% | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 835.04% | -33,882.46% | 2,919.10% | 587.14% | -- |